ISRCTN51530527暂停未知
Virtual HDU Phase 4: Ambulatory monitoring system user interface integration and development.
试验速览
- 阶段
- 未知
- 状态
- 暂停
- 入组人数
- 78
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Stage A: Staff Focus Group/Interviews
- •1. Any clinical staff member who uses SEND or measures patient vital signs
- •Study B: Locational testing of AMS
- •1. Willing and able to give informed consent for participation in the study.
- •2. Aged 18 years or above.
- •3. Admitted to a surgical emergency unit (including post-ICU patients) and not currently monitored with continuous monitoring
- •Study C: Usability Testing
- •1. Any clinical staff member who uses SEND and measures patient vital signs
- •2. Any staff member who may be an end user of a AMS-SEND system
排除标准
- •Stage A: Staff Focus Group/Interviews
- •1. Any staff member who cannot give informed consent
- •Stage B: Locational testing of AMS
- •1. Allergies to nickel.
- •2. Intra-cardiac device
- •3. Already on continuous monitoring
- •4. Diagnosed dementia
- •Stage C: Usability testing
- •1. Any staff member who cannot give informed consent
研究者
相似试验
进行中（未招募）
Unknown
Home monitoring for acutely unwell patients being managed at home as part of a virual ward care pathway: a feasibility studyAcutely unwell patients receiving care from the Oxford University Hospital (OUH) acute hospital-at-home servicesSigns and SymptomsISRCTN11298549niversity of Oxford35
进行中（未招募）
不适用
A Phase IV, Multi-Center, Active-Controlled, Observer-Blind Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced either in Mammalian Cell Culture (Optaflu®) or in Embryonated Hen Eggs (Agrippal®) in Adults and Elderly With and Without Underlying Medical Conditions, and to Evaluate the Immunogenicity in a Subset of Subjects With Underlying Medical Conditions.no medical condition: healthy subjectsEUCTR2007-002872-32-DEovartis Vaccines and Diagnostics S.r.l.
已完成
不适用
A Multicenteric study to estimate the burden of rotavirus gastroenteritis among hospitalization due to diarrhea.CTRI/2012/03/002475Shantha Biotechnics Limited2,000
进行中（未招募）
1 期
A Phase IV, Single-Centre, Observer-Blind, Controlled, Randomized Study to Compare the Safety and Immunogenicity of Fluvirin® to Influvac® Administered to Healthy Children 3 to 12 Years of Age. - Fluvirin Paediatric TrialEUCTR2006-002649-35-GBovartis Vaccines and Diagnostics S.r.l.
尚未招募
4 期
Hospital centralized monitoring of clinical safety of Shenkang Injection after marketing/AITMCTR2100005034The First Affiliated Hospital of He'nan University of Chinese Medicine